School of Medicine

Researchers at Washington University School of Medicine in St. Louis and the Brown School are working together to decrease the burden of COVID-19 on a vulnerable group. The School of Medicine will offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers, and staff in the six special education schools operated by the Special School District of St. […]

A new study from the School of Medicine shows that whole genome sequencing is at least as accurate — and often better than — conventional genetic tests that help determine the treatment for a patient’s blood cancer.

When the crowdsourced supercomputing project Folding@home first announced a shift to coronavirus research and asked for new volunteers to run its software and expand its computing capacity, organizations and citizen scientists from all walks of life heeded the call. Now, about four months later, the number of volunteers has increased a hundredfold. Based at Washington University School of […]

Scientists at the School of Medicine have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection. The study was published in The Journal of Immunology.

Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose, and is effective in preventing infection in mice susceptible to the novel coronavirus. The investigators—Michael S. Diamond,  MD, PhD the Herbert S. Gasser Professor of Medicine and […]

Washington University pediatricians who treat patients at St. Louis Children’s Hospital are part of a major research effort to investigate how the novel coronavirus affects children and young adults, including its role in a rare but serious inflammatory syndrome.

Gregory Bowman, associate professor of biochemistry and molecular biophysics at the School of Medicine, received a three-year $1,763,634 grant award from the National Institute on Aging of the National Institutes of Health (NIH) for his research titled “Structural basis for ApoE4-induced Alzheimer’s disease.”

A new study from Washington University School of Medicine in St. Louis and the National Cancer Institute finds a possible link between slow walking pace and an increased risk of death among cancer survivors.

School of Medicine researchers have found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus, potentially undermining the effectiveness of vaccines and antibody-based drugs being used to prevent or treat COVID-19.

The drug buprenorphine is an effective treatment for opioid use disorder, but many who misuse opioids also take benzodiazepines to treat anxiety and similar conditions. School of Medicine researchers found that buprenorphine lowered the overdose risk, even in people who also took benzodiazepines such as Valium or Xanax.